Techniques for pharmacological and toxicological studies with isolated hepatocyte suspensions

doi:10.1016/0024-3205(92)90212-8

Life Sciences

Volume 51, Issue 1, 1992, Pages 1-16

https://doi.org/10.1016/0024-3205(92)90212-8 Get rights and content

Abstract

Since its introduction in 1969, the high-yield preparation of isolated hepatocytes has become a frequently used tool for the study of hepatic uptake, excretion, metabolism and toxicity of drugs and other xenobiotics. Basic preparative methods are now firmly established involving perfusion of the liver with a balanced-saline solution containing collagenase. Satisfactory procedures are available for determining cell yields, for expressing cellular activities and for establishing optimal incubation conditions. Gross cellular damage can be detected by means of trypan blue or by measuring enzyme leakage, and damaged cells can be removed from the preparation. Specialized techniques are available for preparing hepatocyte couplets and suspensions enriched with periportal or perivenous hepatocytes.

The isolated hepatocyte preparation is particularly convenient for the study of the kinetics of hepatic drug uptake and excretion because the cells can be rapidly separated from the incubation medium. Isolated liver cells have also proved valuable for investigating drug metabolism since they show many of the features of the intact liver. However, they also show important differences such as losses of membrane specialization, some degree of cell polarity and the capacity to form bile. The many consequences of the hepatic toxicity of xenobiotics including lipid peroxidation, free radical formation, glutathione depletion, and covalent binding to macromolecules are also readily studied with the isolated liver cell preparation. A particular advantage is the ease with which morphological changes as a result of drug exposure can be observed in isolated hepatocytes. However, it must be remembered that the isolation procedure inevitably introduces changes that may make the cells more susceptible than the normal liver to damage by xenobiotic agents. Despite its limitations, the isolated hepatocyte preparation is now firmly established in the armamentarium of the investigator examining the interaction of the liver with xenobiotics.

References (237)

P.O. Seglen
Methods Cell Biol.
(1976)
A.J. Paine
Chem. Biol. Interact.
(1990)
V. Rogiers et al.
Biochem. Pharmacol.
(1990)
O. Barnabei et al.
Biochim. Biophys. Acta
(1974)
P.O. Seglen
Exp. Cell Res.
(1972)
D.N. Wheatley
Exp. Cell Res.
(1972)
H.J. Phillips
Tissue Culture
C.A. Tyson et al.
The Isolated Hepatocyte
J.P. Mapes et al.
FEBS Lett.
(1975)
R.A. Jorgenson et al.
J. Biol. Chem.
(1980)

H. Vaananen et al.

Liver

(1983)

B. Quistorff et al.

Acta Pharmacol. Toxicol.

(1984)

A. Guillouzo

A.E. Sirica et al.

Pharmacol. Rev.

(1980)

C. Guguen-Guillouzo et al.

Xenobiotica

(1988)

D.J. Waxman et al.

Biochem. J.

(1990)

E.G. Schuetz et al.

J. Cell Physiol.

(1988)

W.J. Lindblad et al.

Hepatology

(1991)

M.N. Berry et al.

Isolated Hepatocytes Preparation, Properties and Applications

(1991)

M.T. Donato et al.

Cell Biol. and Toxicol.

(1991)

M.J. Meredith

Cell Biol. Toxicol.

(1988)

P. Kremers

M.N. Berry et al.

S.R. Wang et al.

H. Baur et al.

Hoppe Seyler's Z. Physiol. Chem.

(1975)

H.-A. Kolb et al.

J. Membr. Biol.

(1976)

Cited by (83)

Pharmacological potential of Astragali Radix for the treatment of kidney diseases
2024, Phytomedicine
With the increasing prevalence of hypertension, diabetes, and obesity, the incidence of kidney diseases is also increasing, resulting in a serious public burden. Conventional treatments for kidney diseases have unsatisfactory effects and are associated with adverse reactions. Traditional Chinese medicines have good curative effects and advantages over conventional treatments for preventing and treating kidney diseases. Astragali Radix is a Chinese herbal medicine widely used to treat kidney diseases.
To review the potential applications and molecular mechanisms underlying the renal protective effects of Astragali Radix and its components and to provide direction and reference for new therapeutic strategies and future research and development of Astragali Radix.
PubMed, Google Scholar, and Web of Science were searched using keywords, including “Astragali Radix,” “Astragalus,” “Astragaloside IV” (AS-IV), “Astragali Radix polysaccharide” (APS), and “kidney diseases.” Reports on the effects of Astragali Radix and its components on kidney diseases were identified and reviewed.
The main components of Astragali Radix with kidney-protective properties include AS-IV, APS, calycosin, formononetin, and hederagenin. Astragali Radix and its active components have potential pharmacological effects for the treatment of kidney diseases, including acute kidney injury, diabetic nephropathy, hypertensive renal damage, chronic glomerulonephritis, and kidney stones. The pharmacological effects of Astragali Radix are manifested through the inhibition of inflammation, oxidative stress, fibrosis, endoplasmic reticulum stress, apoptosis, and ferroptosis, as well as the regulation of autophagy.
Astragali Radix is a promising drug candidate for treating kidney diseases. However, current research is limited to animal and cell studies, underscoring the need for further verifications using high-quality clinical data.
Study of dietary curcumin on the restorative effect of liver injury induced by carbon tetrachloride in common carp, Cyprinus carpio
2021, Aquaculture Reports
Carbon tetrachloride (CCl₄) can be decomposed into free radicals, which cause lipid peroxidation, thereby damaging liver cells, and resulting in the death of aquatic animals. The present study was to investigate the recovery effect and possible mechanism of dietary curcumin against liver injury in Cyprinus carpio induced by CCl₄. The experiment was divided into four groups. Two control groups were fed with a basal feed (the negative control, P1 and the positive control, P2), and two treatment groups were fed with feeds supplemented with 120 and 240 mg kg⁻¹ for the entire 10-week study duration, respectively (P3 and P4). At the end of the feeding period, the CCl₄ solution (CCl₄ was dissolved in olive oil at 30 %, 0.5 mL per 100 g body weight) was injected into the abdominal cavity of P1, P3 and P4 groups. And the P2 group was injected with olive oil in the same proportion. On days 2, 3, 5 and 7 after CCl₄ challenge, samples were taken separately to investigate the effect of curcumin on the liver injury induced by CCl₄ in fish. Results showed that plasma alanine transaminase (ALT)and aspartate aminotransferase (AST) avtivities of fish increased significantly, relative to pre-challenge levels, 2 day after CCl₄-challenge in P1, P3 and P4 groups (P<0.05), and the avtivities of plasma ALT and AST in these groups decreased as challenge time from 2 day to 7day. Liver total superoxide dismutase (SOD) and glutathione peroxidase (GSH-Px) activities and glutathione (GSH) content of fish in P1, P3 and P4 groups decreased firstly and then increased with increasing challenge time, however, the content of liver malondiadehyde (MDA) was contrary. Curcumin (120 mg kg^-1 curcumin per feed) inhibited the damage of liver tissue structure caused by CCl₄ and made liver tissue structure return to normal. Meanwhile, dietary curcumin supplementation could also increase the live nuclear factor crythroid 2-related factor 2 (Nrf2) mRNA level and Nrf2 protein level in the liver nucleus, especially 120 mg kg^-1 feed. Overall, the results indicated that feed supplemented with curcumin could effectively protect the liver against CCl₄ induced injury. And the 120 mg kg⁻¹ curcumin group had the better restorative effect of liver injury compared with the high-dose group.
Protective function on liver and proteomic analysis of the improvement mechanism of Sedum sarmentosum Bunge extract on nonalcoholic fatty liver disease in Nile tilapia
2021, Aquaculture
Citation Excerpt :
In humans and mice, many biochemical parameters have been found to be altered in NAFLD including pathological indexes, enzymic markers, inflammatory regulators and factors (Berry et al., 1992; Pawlak et al., 2015). Previous studies have demonstrated that the expression levels of lipid metabolism-related proteins (FAS and L-FABP), lipid metabolites (FFA and TG), and linoleic acid are altered in NAFLD (Berry et al., 1992; Wu et al., 2014; Zhang et al., 2015; Xie et al., 2016). These factors participate in lipid synthesis, storage, transport and catabolism; and are regulated by multiple transcription factors including PPARs, X receptors, and cAMP response element-binding protein (Anderson et al., 2004; Calkin and Tontonoz, 2012; Zhang et al., 2012).
Nonalcoholic fatty liver disease (NAFLD) caused by high-fat diet (HFD) feeding in fish has greatly impacted the aquaculture industry in a negative way. In order to investigate the effect of Sedum sarmentosum Bunge (SSB) extract on liver function and differentially expressed protein (DEP) profiles in NAFLD, Nile tilapia NAFLD model was constructed. Indicators of liver functions, blood lipid levels, and levels of antioxidant enzymes were evaluated. LC-MS/MS analysis was employed to identify DEPs for exploring the potential mechanism underlying the protective effect of SSB against NAFLD. Parallel reaction monitoring (PRM) was performed to verify the results of proteomic analysis. Growth, hepatosomatic index, hepatocyte apoptosis, levels of liver function indicators (AST, ALT, LDH, and TBA), and levels of blood lipids (CHOL and TG) were increased, and the mRNA and protein levels of antioxidant enzymes (HL and CAT) were decreased in HFD-fed tilapia as compared to normal diet-fed tilapia; notably, treatment with SSB extract reversed these alterations. A total of 302 DEPs were identified in the liver tissues of HFD-fed tilapia in comparison with normal diet-fed tilapia, of which regulation of 78 DEPs were significantly reversed by SSB treatment. Kyoto Encyclopedia of Genes and Genomes (KEGG) and protein–protein interaction (PPI) analysis showed that the 302 DEPs were enriched in processes such as fatty acid biosynthesis, steroid biosynthesis, lipid metabolism, and apoptosis, which are associated with development of NAFLD. Furthermore, results of PRM validation showed that the expression ratios of nine proteins were in accordance with the results of proteomic analysis. Our study reveals that SSB extract has a hepatoprotective role in Nile tilapia with HFD-induced NAFLD, and the observed changes in the DEP profiles indicate that SSB exerts its protective effects via regulation of lipid metabolism, steroid biosynthesis, and apoptosis.
Hepatoprotective and antioxidant effects of dietary Glycyrrhiza polysaccharide against TCDD-induced hepatic injury and RT-PCR quantification of AHR2, ARNT2, CYP1A mRNA in Jian Carp (Cyprinus carpio var. Jian)
2017, Journal of Environmental Sciences (China)
Citation Excerpt :
The activity and leakage of cytosolic enzymes (GOT, GPT, AKP, LDH) have frequently been used to assess liver toxicity caused by chemical drugs (Fouzy et al., 2007; Turkez et al., 2016). GPT, GOT and LDH, the soluble enzymes, were found to be released from the cytoplasm of liver cells (Berry et al., 1992; Mitra et al., 1998; Romero et al., 1998), and their activities have been considered as classical indicators of liver or hepatocyte injury (Kalaiselvan et al., 2016; Turkez et al., 2016). Alkaline phosphatase (AKP) is an isoenzyme and widely distributed in the liver.
To evaluate the protective effects of Glycyrrhiza polysaccharide (GPS) against 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced hepatotoxicity in Jian carp, the fish were fed diets containing GPS at doses of 0.1, 0.5 and 1.0 g/kg for 60 days before an intraperitoneal injection of 0.6 μg/kg TCDD at a volume of 0.05 mL/10 g body weight. At 72 hr post-injection, blood and liver samples were taken for biochemical analysis and the fish liver samples were used for the preparation of pathological slices. The results showed that increases in alanine aminotransferase (GPT), aspartate aminotransferase (GOT), lactate dehydrogenase (LDH), and alkaline phosphatase (AKP) in serum induced by TCDD were significantly inhibited by pre-treatment with 1.0 g/kg GPS. Following the 1.0 g/kg GPS pre-treatment, total protein (TP), albumin (Alb), catalase (CAT), glutathione peroxidase (GPx), total antioxidant capacity (T-AOC) and superoxide dismutase (SOD) activities in liver tissue increased significantly, malondialdehyde (MDA) formation (P < 0.05 or P < 0.01) was significantly inhibited, and the expression of cytochrome P4501A (CYP1A), aryl hydrocarbon receptor 2 (AHR2) and aryl hydrocarbon receptor nuclear translocator 2 (ARNT2) mRNA (P < 0.05) was significantly enhanced. Histological observations on fish liver were obtained by preparing paraffin tissue sections via HE staining, and the results showed that histological changes were obviously reduced by 0.5 and 1.0 g/kg GPS. GPS significantly reduced liver tissue damage caused by TCDD. Overall, these results proved the hepatoprotective effect of GPS in protecting against fish liver injury induced by TCDD, and supported the use of GPS (1.0 g/kg) as a hepatoprotective and antioxidant agent in fish.
Effects of curcumin on antioxidative activities and cytokine production in Jian carp (Cyprinuscarpio var. Jian) with CCl<inf>4</inf>-induced liver damage
2015, Fish and Shellfish Immunology
Citation Excerpt :
The expression of IL-1β, TNF-α and IL-12 mRNAs was also significantly increased after CCl4 treatment (P < 0.01; Fig. 7A–C), whereas the expression of IL-1β and TNF-α mRNAs in the liver was significantly reduced in the carp fed 0.5% and 1.0% curcumin for 60 days and then treated with CCl4 compared with those treated with CCl4 alone (P < 0.05; Fig. 7A,B) and IL-12 mRNA expression in the liver was significantly reduced after CCl4 treatment in the carp fed with any dose of curcumin (P < 0.05; Fig. 7C). It has been demonstrated that CCl3O2·, the metabolite of CCl4, causes lipid peroxidation, blocking the production of membrane proteins and resulting in the exudation of soluble cytoplasmic enzymes and increased serum GOT, GPT, and LDH [25]. In this study, 0.5% and 1.0% curcumin significantly inhibited the increased serum GOT levels induced by CCl4 in Jian carp, and 1.0% curcumin markedly suppressed the increases in serum GPT and LDH induced by CCl4.
We investigated the protective effects of curcumin on liver-damaged Cyprinus carpio var. Jian (Jian carp). The carp were fed 0.1%, 0.5%, or 1.0% curcumin for 60 days, then injected intraperitoneally with 30% carbon tetrachloride solution. Liver and blood samples were collected to measure the liver index, serum- and liver-associated enzymes, liver histology, nuclear factor-κB (NF-κB)/c-Rel, interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), and IL-12 mRNA expression, and the level of NF-κB/c-Rel protein in the liver, and for a comet assay. We found that 0.5% and 1.0% curcumin significantly reduced the CCl₄-induced increase in the liver index. The comet assay showed that the tail moment, olive tail moment, tail length, and tail DNA% improved in fish pretreated with 0.5 or 1.0% curcumin. CCl₄-induced histological changes, including extensive hepatocyte degeneration, indistinct cell borders, nuclear condensation, and karyolysis were clearly reduced after treatment with 0.5% and 1.0% curcumin. Moreover, 0.5% and 1.0% curcumin significantly inhibited the CCl₄-induced increase in serum glutamic oxaloacetic transaminase and promoted the restoration of superoxide dismutase in the liver; 1.0% curcumin significantly reduced serum glutamic pyruvic transaminase and lactate dehydrogenase and hepatic malondialdehyde, but significantly increased the total antioxidant capacity and glutathione levels in the liver. The CCl₄-induced upregulation of NF-κB/c-Rel, IL-1β, and TNF-α mRNAs and NF-κB/c-Rel protein levels was inhibited by 0.5% and 1.0% curcumin, and IL-12 mRNA was reduced by all three doses of curcumin. The effects of curcumin on the liver index, enzymes, histological changes, and cytokines were dose-dependent. Our results indicate that curcumin reduces CCl₄-induced liver damage in Jian carp by upregulating antioxidative activities and inhibiting NF-κB, IL-1β, TNF-α, and IL-12 expression.
Revival, characterization, and hepatitis B virus infection of cryopreserved human fetal hepatocytes
2014, Journal of Virological Methods
Primary human hepatocytes are considered the ideal cellular model for in-vitro studies of liver-specific pathology, such as hepatitis B virus (HBV) infection. However, poor accessibility, limited cell numbers, and lot-to-lot variation of primary human hepatocytes limit their broad application. Human fetal hepatocytes were isolated from postmortem embryonic liver tissues by two-step collagenase perfusion and cryopreserved. A monolayer of cryopreserved human fetal hepatocytes was established by optimizing such conditions as cell density and viability and purification of viable cells by Percoll. Finally, revived human fetal hepatocytes were characterized and infected with HBV. A large number of viable human fetal hepatocytes could be isolated and cryopreserved, with seeding density and viability being critical for the establishment of a compact monolayer culture. Using low-viability cryopreserved human fetal hepatocytes, a typical monolayer was established by purification with Percoll. The revived cells were actively proliferative, showed identical morphologic characteristics to non-cryopreserved cells, and had a typical hepatic gene expression profile. Moreover, this optimized model was susceptible to HBV infection and could be used to screen entry inhibitors against HBV infection. In conclusion, these methods can be used on human fetal hepatocytes to provide a cell bank for studies of the early stages of HBV infection.

View all citing articles on Scopus

View full text

MinireviewTechniques for pharmacological and toxicological studies with isolated hepatocyte suspensions

Abstract

Methods Cell Biol.

Chem. Biol. Interact.

Biochem. Pharmacol.

Biochim. Biophys. Acta

Exp. Cell Res.

Exp. Cell Res.

FEBS Lett.

J. Biol. Chem.

Biochim. Biophys. Acta

Toxicol. Appl. Pharmacol.

Biochim. Biophys. Acta

Biochem. Pharmacol.

Arch. Biochem. Biophys.

Biochem. Pharmacol.

Biochem. Biophys. Res. Commun.

Toxicol. Appl. Pharmacol.

Anal. Biochem.

J. Biol. Chem.

Biochim. Biophys. Acta

Biochim. Biophys. Acta

Gastroenterology

J. Biol. Chem.

Biochem. Pharmacol.

Biochem. Pharmacol.

J. Biol. Chem.

Biochem. Pharmacol.

Biochem. Pharmacol.

Life Sci.

Biochem. Pharmacol.

Biochem. Pharmacol.

J. Cell Biol.

Methods Enzymol.

Liver

Acta Pharmacol. Toxicol.

Pharmacol. Rev.

Xenobiotica

Biochem. J.

J. Cell Physiol.

Hepatology

Isolated Hepatocytes Preparation, Properties and Applications

Cell Biol. and Toxicol.

Cell Biol. Toxicol.

Hoppe Seyler's Z. Physiol. Chem.

J. Membr. Biol.

Minireview
Techniques for pharmacological and toxicological studies with isolated hepatocyte suspensions